Currency converter
26 Nov 2024 22:59
(-0.06%)
Closing price, the previous day.
Opening price.
The highest price over the last trading day.
The lowest price over the last trading day
Price range high in the last week
Price range low in the last week
Il y a maintenant plus de 7 millions de traders dans notre équipe! Chaque jour nous travaillons à améliorer le trading. On s'efforce de vous offrir le meilleur et on obtient les plus beaux succès.
La confiance de millions de traders partout dans le monde est l'évaluation la plus élevée de notre travail!
Vous avez fait votre choix et nous allons faire de notre mieux pour répondre à vos attentes!
Ensemble, nous faisons une super équipe!
InstaSpot est fier de vous servir!
L'acteur, le champion de l'UFC et un vrai bogatyr russe! . Homme qui ne doit sa réussite qu'à lui-même. L'homme qui est sur la même route que nous suivons.
Le secret du succès de Taktarov est le progrès permanent vers la réalisation de son objectif.
Découvrez toutes les facettes de votre talent! Apprenez, essayez, commettez des erreurs, mais ne vous arrêtez pas!
InstaSpot - L'histoire de votre succès commence ici !
AbbVie Inc. is an American biopharmaceutical company. It was founded in 2013 after Abbott Laboratories split into two separate companies. In the same year, AbbVie Inc. was listed on the New York Stock Exchange as a separate company under the ABBV ticker.
The company’s mission is to develop and deliver innovative medicines that solve serious health issues. Since its foundation, the company has invested more than $50 billion in the research and development of world-class medicines.
Nowadays, it employs more than 50,000 people worldwide. Its production facilities and research centers are located in 20 countries.
In 2021, the company's total revenue amounted to $56.2 billion. AbbVie's GAAP net profit for the 6 months of 2022 totaled $5.42 billion, an increase of 25.4% compared to $4.32 billion in the previous year. Its revenue jumped by 4.3% to $28.12 billion against $26.97 billion a year earlier.
Currently, the company's shares are traded between $140-145, which is four times higher since its IPO 10 years ago. Over the past year, the stock price has fluctuated in the range of $106.86 -$175.91.
Its shares are growing slowly but surely without sharp price swings. Thus, the purchase of AbbVie Inc. stock can be deemed a good long-term investment.
AbbVie allocates 45-50% of available funds annually to pay dividends to its shareholders. The amount of dividends is quite decent. For this reason, the company is classified as a dividend aristocrat.